Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E4 in sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Urine albumin excretion (UAE) is predictive of subclinical cardiovascular diseases associated with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Urinary excretion of sodium correlates with severity of obstructive sleep-disordered breathing in children Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Urinary biomarkers for obstructive sleep apnea syndrome: Lipocalin type prostaglandin-D synthase and F2-isoprostane Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Renin and aldosterone levels in obstructive sleep apnea syndrome patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Visfatin levels in sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Sleep apnoea syndrome, a causative factor of nocturnal microalbuminuria Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Evaluation of the levels of the ultrasensitive C-reactive protein (CRPus) in subjects with obstructive sleep apnea- hypopnea syndrome Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Prevalence of nocturia in obstructive sleep apnea syndrom Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Sleep apnoea-hypopnoea syndrome in acromegalic patients Source: Eur Respir J 2006; 28: Suppl. 50, 417s Year: 2006
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013